Atrial Fibrillation Perspective

 
 

  • Feb 5 2021 This Week in Cardiology   Carotid screening, AF and alcohol, subcutaneous ICD, and medical education are the topics discussed by John Mandrola, MD, in this week’s podcast.
  • Jan 29 2021 This Week in Cardiology   AF and COVID-19, microthrombi in COVID-19 autopsies, vericiguat, and POTS are the topics covered by John Mandrola, MD, in this week’s podcast.
  • Antiplatelet Therapy: Where Do We Stand Now?   Can duration of DAPT be shortened? Is single antiplatelet therapy an option? Drs Bangalore and Baber discuss these topics in antiplatelet therapy and more.
  • ECG Challenge: Did COPD Cause This Man's Irregular Heart Rate? A middle-aged COPD patient is intubated after experiencing respiratory distress and is found to have an irregular heartbeat. What does his ECG show?
  • Jan 15 2021 This Week in Cardiology   COVID, ACE/ARBs, left atrial appendage closure, SGLT2 inhibitors, and a clue in AF mechanisms are the topics discussed by John Mandrola, MD, in this week’s podcast.
  • Highlights in Mantle Cell Lymphoma From ASH 2020   Dr Amanda Cashen from Washington University reviews key studies on mantle cell lymphoma from ASH 2020, including new data on chemotherapy-free frontline options and CAR T-cell therapy.
  • Mandrola's Top 10 in Cardiology for 2020 While the pandemic dominated the medical news, there were both exciting and concerning developments in the world of cardiology.
  • Dec 11 2020 This Week in Cardiology   COVID, the clogged pipe frame of CAD, paclitaxel, and AF performance measures and Goodhart’s law are the topics John Mandrola, MD, covers in this week’s podcast.
  • Fish Oils and CV Prevention -- Now What?   Drs Tracy Wang and Renate Schnabel discuss new data on omega-3 fatty acids from the REDUCE-IT trial of icosapent ethyl. Do the STRENGTH, OMEMI, and VITAL Rhythm trials from the AHA meeting raise concerns?
  • Nov 20 2020 This Week in Cardiology   COVID-19 vaccines and virtual AHA presentations on statins and the nocebo effect, high dose omega-3s, and AF ablation are the topics John Mandrola, MD, discusses on this week’s podcast.
  • AHA 2020 EARLY-AF and STOP AF Put Electrophysiology at a Crossroads Seemingly positive data on earlier use of catheter ablation in patients with atrial fibrillation concerns some electrophysiologists.
  • Nov 13 2020 This Week in Cardiology   COVID19 vaccines, thrombolysis in stroke, industry payments to doctors, and the upcoming AHA are topics covered by John Mandrola, MD, in this week’s podcast.
  • AHA 2020 Read clinically focused news coverage of key developments from AHA 2020
  • Mandrola Previews AHA 2020 A trial that aims to answer whether statin myalgia is drug related tops the picks. Studies on CT angiography, AF monitoring, fish oils, and a novel MRA will also feature at the 2020 American Heart Association meeting.
  • Nov 6 2020 This Week in Cardiology   COVID, AF ablation, pediatric “do not dos” from AAP, heart failure performance measures, and a brief AHA preview are the topics discussed by John Mandrola, MD on this week’s podcast.
  • Surgery Still Best Option in Obstructive HCM Promising results for a novel drug should not push surgical options aside for patients with obstructive hypertrophic cardiomyopathy, argue two surgeons.
  • ESC 2020 Highlights: Treatment Strategies and the Virtual Experience   The first randomized trial on stopping ACE inhibitors and ARBs in patients with COVID-19, and a comparison of rhythm vs rate control in AF are among the strategies tested in trials presented at ESC 2020.
  • HFpEF Management: 5 Things to Know Although proven medical therapies for HFpEF are few, a stepwise set of management practices can help optimize care for patients with this condition.
  • Smart Health Devices: Promises and Pitfalls What needs to be done before the data deluge hits the office.
  • Sep 25 2020 This Week in Cardiology   COVID sport participation guidelines, beta-blockers after MI, and low-dose DOAC therapy in AF are the topics covered by John Mandrola, MD, in this week’s podcast.